129 related articles for article (PubMed ID: 34229002)
21. Hierarchy of the Components in Spray-Dried, Protein-Excipient Particles Using DNP-Enhanced NMR Spectroscopy.
Berruyer P; Lindkvist M; Gracin S; Starciuc T; Bertarello A; Busi B; Schantz S; Emsley L
Mol Pharm; 2023 Nov; 20(11):5682-5689. PubMed ID: 37782000
[TBL] [Abstract][Full Text] [Related]
22. Spray-Dried Influenza Antigen with Trehalose and Leucine Produces an Aerosolizable Powder Vaccine Formulation that Induces Strong Systemic and Mucosal Immunity after Pulmonary Administration.
Sou T; Morton DA; Williamson M; Meeusen EN; Kaminskas LM; McIntosh MP
J Aerosol Med Pulm Drug Deliv; 2015 Oct; 28(5):361-71. PubMed ID: 25714115
[TBL] [Abstract][Full Text] [Related]
23. Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin.
Shetty N; Ahn P; Park H; Bhujbal S; Zemlyanov D; Cavallaro A; Mangal S; Li J; Zhou QT
Mol Pharm; 2018 Sep; 15(9):4004-4020. PubMed ID: 30028947
[TBL] [Abstract][Full Text] [Related]
24. Lipid-microparticles for pulmonary delivery of active pharmaceutical ingredients: Impact of lipid crystallization on spray-drying processability.
Corzo C; Fuchsbichler A; Savencu I; Afonso Urich J; Zimmer A; Lochmann D; Reyer S; Salar-Behzadi S
Int J Pharm; 2021 Dec; 610():121259. PubMed ID: 34740761
[TBL] [Abstract][Full Text] [Related]
25. Spray Dried Rugose Lipid Particle Platform for Respiratory Drug Delivery.
Wang H; Ordoubadi M; Connaughton P; Lachacz K; Carrigy N; Tavernini S; Martin AR; Finlay WH; Lechuga-Ballesteros D; Vehring R
Pharm Res; 2022 Apr; 39(4):805-823. PubMed ID: 35364777
[TBL] [Abstract][Full Text] [Related]
26. Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer.
Meenach SA; Anderson KW; Zach Hilt J; McGarry RC; Mansour HM
Eur J Pharm Sci; 2013 Jul; 49(4):699-711. PubMed ID: 23707466
[TBL] [Abstract][Full Text] [Related]
27. Amino acids as stabilizers for spray-dried simvastatin powder for inhalation.
Lu W; Rades T; Rantanen J; Chan HK; Yang M
Int J Pharm; 2019 Dec; 572():118724. PubMed ID: 31678523
[TBL] [Abstract][Full Text] [Related]
28. Protection of hydrophobic amino acids against moisture-induced deterioration in the aerosolization performance of highly hygroscopic spray-dried powders.
Yu J; Chan HK; Gengenbach T; Denman JA
Eur J Pharm Biopharm; 2017 Oct; 119():224-234. PubMed ID: 28655664
[TBL] [Abstract][Full Text] [Related]
29. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
[TBL] [Abstract][Full Text] [Related]
30. Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension.
Shahin HI; Vinjamuri BP; Mahmoud AA; Shamma RN; Mansour SM; Ammar HO; Ghorab MM; Chougule MB; Chablani L
J Control Release; 2019 May; 302():126-139. PubMed ID: 30940497
[TBL] [Abstract][Full Text] [Related]
31. Characterization of spray dried powders with nucleic acid-containing PEI nanoparticles.
Keil TWM; Feldmann DP; Costabile G; Zhong Q; da Rocha S; Merkel OM
Eur J Pharm Biopharm; 2019 Oct; 143():61-69. PubMed ID: 31445157
[TBL] [Abstract][Full Text] [Related]
32. Force control and powder dispersibility of spray dried particles for inhalation.
Weiler C; Egen M; Trunk M; Langguth P
J Pharm Sci; 2010 Jan; 99(1):303-16. PubMed ID: 19533606
[TBL] [Abstract][Full Text] [Related]
33. Amorphous pullulan trehalose microparticle platform for respiratory delivery.
Carrigy NB; Ordoubadi M; Liu Y; Melhem O; Barona D; Wang H; Milburn L; Ruzycki CA; Finlay WH; Vehring R
Int J Pharm; 2019 May; 563():156-168. PubMed ID: 30951858
[TBL] [Abstract][Full Text] [Related]
34. Preparation and in vivo absorption evaluation of spray dried powders containing salmon calcitonin loaded chitosan nanoparticles for pulmonary delivery.
Sinsuebpol C; Chatchawalsaisin J; Kulvanich P
Drug Des Devel Ther; 2013; 7():861-73. PubMed ID: 24039397
[TBL] [Abstract][Full Text] [Related]
35. Manufacturing of High-Concentration Monoclonal Antibody Formulations via Spray Drying-the Road to Manufacturing Scale.
Gikanga B; Turok R; Hui A; Bowen M; Stauch OB; Maa YF
PDA J Pharm Sci Technol; 2015; 69(1):59-73. PubMed ID: 25691715
[TBL] [Abstract][Full Text] [Related]
36. A Design of Experiment (DoE) approach to optimise spray drying process conditions for the production of trehalose/leucine formulations with application in pulmonary delivery.
Focaroli S; Mah PT; Hastedt JE; Gitlin I; Oscarson S; Fahy JV; Healy AM
Int J Pharm; 2019 May; 562():228-240. PubMed ID: 30849470
[TBL] [Abstract][Full Text] [Related]
37. Effect of formulation and inhaler parameters on the dispersion of spray freeze dried voriconazole particles.
Liao Q; Lam ICH; Lin HHS; Wan LTL; Lo JCK; Tai W; Kwok PCL; Lam JKW
Int J Pharm; 2020 Jun; 584():119444. PubMed ID: 32445908
[TBL] [Abstract][Full Text] [Related]
38. Investigation of the Changes in Aerosolization Behavior Between the Jet-Milled and Spray-Dried Colistin Powders Through Surface Energy Characterization.
Jong T; Li J; Morton DA; Zhou QT; Larson I
J Pharm Sci; 2016 Mar; 105(3):1156-63. PubMed ID: 26886330
[TBL] [Abstract][Full Text] [Related]
39. Spray-dried respirable powders containing bacteriophages for the treatment of pulmonary infections.
Matinkhoo S; Lynch KH; Dennis JJ; Finlay WH; Vehring R
J Pharm Sci; 2011 Dec; 100(12):5197-205. PubMed ID: 22020816
[TBL] [Abstract][Full Text] [Related]
40. Protective effect of sodium stearate on the moisture-induced deterioration of hygroscopic spray-dried powders.
Yu J; Romeo MC; Cavallaro AA; Chan HK
Int J Pharm; 2018 Apr; 541(1-2):11-18. PubMed ID: 29454904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
